Ischemic preconditioning attenuates renal ischemia-reperfusion injury by inhibiting activation of IKKβ and inflammatory response

American Journal of Nephrology

Volumn 30, Issue 3, 2009, Pages 287-294

  Chen, Xin ^a   Liu, Xiaodong ^a   Wan, Xin ^a   Wu, Yu ^a   Chen, Yu ^a   Cao, Changchun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Acute kidney ischemia; I kappaB kinase (IKK ); Ischemia preconditioning; Neutrophil gelatinase associated lipocalin (NGAL)

Indexed keywords

BIOLOGICAL MARKER; CREATININE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EXPERIMENTAL ANIMAL; HISTOPATHOLOGY; INFLAMMATION; ISCHEMIC PRECONDITIONING; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; KIDNEY TUBULE; MALE; NEPHRECTOMY; NEUTROPHIL; NONHUMAN; PARAMETER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RENAL ARTERY; REPERFUSION INJURY; SHAM PROCEDURE; SPRAGUE DAWLEY RAT;

ANIMALS; I-KAPPA B KINASE; INFLAMMATION; ISCHEMIC PRECONDITIONING; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 67449138487     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000225928     Document Type: Article

References (36)

1. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004; 114: 5-14.
2. Lameire N, Van BW, Vanholder R: Acute renal failure. Lancet 2005; 365: 14.
3. Devarajan P: Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17: 1503-1520.
4. Goldstein SL: Pediatric acute kidney injury: it's time for real progress. Pediatr Nephrol 2006; 21: 891-895.
5. Rosner MH, Okusa MD: Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006; 1: 19-32.
6. Sung FL, Zhu TY, Au-Yeung KK, Siow YL, et al: Enhanced MCP-1 expression during ischemia/ reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int 2002; 62: 1160-1170.
7. Burne-Taney MJ, Liu M, Baldwin WM, Racusen L, et al: Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning. J Immunol 2006; 176: 7015-7020.
8. Jo SK, Ko GJ, Boo CS, Cho WY, et al: Heat preconditioning attenuates renal injury in ischemic ARF in rats: role of heat-shock protein 70 on NF-kappaB-mediated inflammation and on tubular cell injury. J Am Soc Nephrol 2006; 17: 3082-3092.
9. Joo JD, Kim M, D'Agati VD, Lee HT: Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice. J Am Soc Nephrol 2006; 17: 3115-3123.
10. Moss NC, Stansfield WE, Willis MS, Tang RH, et al: IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2007; 293:H2248-H2253.
11. Bennett M, Dent CL, Ma Q, Dastrala S, et al: Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008; 3: 665-673.
12. Mishra J, Mori K, Ma Q, Kelly C, et al: Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2004; 15: 3073-3082.
13. DiDonato JA: Assaying for IkappaB kinase activity. Methods Enzymol 2000; 322: 393-400.
14. Trushin S, Pennington K, Carmona E: Protein kinase C alpha (PKC alpha) acts upstream of PKC theta to activate I B kinase and NF- B in T lymphocytes. Mol Cell Biol 2003; 23: 7068-7081.
15. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
16. Ferencz A, Racz B, Gasz B, Benko L, et al: Intestinal ischemic preconditioning in rats and NF-kappaB activation. Microsurgery 2006; 26: 54-57. (Pubitemid 43244654)
17. Lee HT, Emala CW: Protein kinase C and G(i/o) proteins are involved in adenosine-and ischemic preconditioning-mediated renal protection. J Am Soc Nephrol 2001; 12: 233-240.
18. Torras J, Herrero-Fresneda I, Lloberas N, Riera M, et al: Promising effects of ischemic preconditioning in renal transplantation. Kidney Int 2002; 61: 2218-2227.
19. Sola A, Palacios L, Lopez-Marti J, Ivorra A, et al: Multiparametric monitoring of ischemia- reperfusion in rat kidney: effect of ischemic preconditioning. Transplantation 2003; 75: 744-749.
20. Jefayri MK, Grace PA, Mathie RT: Attenuation of reperfusion injury by renal ischaemic preconditioning: the role of nitric oxide. BJU Int 2000; 85: 1007-1013.
21. Chander V, Chopra K: Role of nitric oxide in resveratrol-induced renal protective effects of ischemic preconditioning. J Vasc Surg 2005; 42: 1198-1205.
22. Yamashita J, Ogata M, Itoh M, Yamasowa H, et al: Role of nitric oxide in the renal protective effects of ischemic preconditioning. J Cardiovasc Pharmacol 2003; 42: 419-427.
23. Timsit M, Gadet R, Ben Abdennebi H, Codas R, et al: Renal ischemic preconditioning improves recovery of kidney function and decreases alpha-smooth muscle actin expression in a rat model. J Urol 2008; 180: 388-391.
24. Li P, Ding XQ, Cao CC: Experimental study of renal ischemic preconditioning and the role of ICAM-1. China J Nephrol 2004; 29.
25. Jiang S, Liu C, Zhang X, Xu X, et al: Renal protection by delayed ischaemic preconditioning is associated with inhibition of the inflammatory response and NF-kappaB activation. Cell Biochem Funct 2007; 25: 335-343.
26. Baldwin AS Jr: Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 2001; 107: 3-6.
27. Hall G, Singh IS, Hester L, Hasday JD, et al: Inhibitor-kappaB kinase-beta regulates LPS-induced TNF-alpha production in cardiac myocytes through modulation of NFkappaB p65 subunit phosphorylation. Am J Physiol Heart Circ Physiol 2005; 289:H2103-H2111.
28. Li C, Kao RL, Ha T, Kelley J, et al: Early activation of IKKbeta during in vivo myocardial ischemia. Am J Physiol Heart Circ Physiol 2001; 280:H1264-H1271.
29. Valen G, Yan ZQ, Hansson GK: Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001; 38: 307-314.
30. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, et al: Differential gene expression following early renal ischemia/reperfusion. Kidney Int 2003; 63: 1714-1724.
31. Mishra J, Ma Q, Prada A, Mitsnefes M, et al: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14: 2534-2543. (Pubitemid 37169339)
32. Mishra J, Mori K, Ma Q, Kelly C, et al: Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004; 24: 307-315.
33. Mori K, Lee HT, Rapoport D, Drexler IR, et al: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115: 610-621.
34. Schmidt-Ott KM, Mori K, Kalandadze A, Li JY, et al: Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2006; 15: 442-449.
35. Tuttle KR, Worrall NK, Dahlstrom LR, Nandagopal R, et al: Predictors of ARF after cardiac surgical procedures. Am J Kidney Dis 2003; 41: 76-83.
36. Bu DX, Hemdahl AL, Gabrielsen A, Fuxe J, et al: Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB. Am J Pathol 2006; 169: 2245-2253.